[1] Hanif H, Ali M J, Susheela A T, et al. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma[J]. World J Gastroenterol,2022,28(2):216-229. [2] Hu X, Chen R, Wei Q, et al. The Landscape of alpha fetoprotein in hepatocellular carcinoma: where are we?[J]. Int J Biol Sci, 2022,18(2):536-551. [3] Johnson P, Zhou Q, Dao D Y, et al. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma[J]. Nat Rev Gastroenterol Hepatol, 2022,19(10):670-681. [4] Tu H, Feng S, Chen L, et al. Contrast enhanced ultrasound combined with serology predicts hepatocellular carcinoma recurrence: a retrospective observation cohort study[J]. Front Oncol, 2023,13(8):e1154064. [5] Ma Q P, He X L, Li K, et al. Dynamic contrast-enhanced ultrasound radiomics for hepatocellular carcinoma recurrence prediction after thermal ablation[J]. Mol Imaging Biol,2021,23(4):572-585. [6] 高小青,姜胜攀,李军,等.肝细胞癌切除术后早期复发和转移的危险因素分析及Nomogram模型构建[J].国际消化病杂志, 2023, 43(5):339-347. [7] 孙林,顾梅秀,屠竞扬,等.术前中性粒细胞/淋巴细胞比值对肝细胞肝癌患者移植术后复发的影响[J].中国临床医学, 2022, 29(6):916-920. [8] 中国临床肿瘤学会指南工作委员会.中国临床肿瘤学会(CSCO)原发性肝癌诊疗指南[M]. 北京:人民卫生出版社:2018. [9] 张瑶瑶,雷芯,戴光荣.AFP阴性肝癌相关血清学标志物的研究进展[J].肝脏, 2023, 28(9):1112-1115. [10] Cai W J, Ying M, Zheng R Q, et al. Contrast-enhanced ultrasound liver imaging reporting and data system in hepatocellular carcinoma ≤5 cm: biological characteristics and patient outcomes[J]. Liver Cancer,2023,12(4):356-371. [11] Zhang H, Huo F. Prediction of early recurrence of HCC after hepatectomy by contrast-enhanced ultrasound-based deep learning radiomics[J]. Front Oncol, 2022,12(9):e930458. [12] Nguyen S A, Merrill C D, Burrowes D P, et al. Hepatocellular carcinoma in evolution: correlation with CEUS LI-RADS[J]. Radiographics, 2022,42(4):1028-1042. [13] Krolak C, Dighe M, Clark A, et al. Quantification of hepatocellular carcinoma vascular dynamics with contrast-enhanced ultrasound for LI-RADS implementation[J]. Invest Radiol, 2024,59(4):337-344. [14] Jin J, Jiang Y, Zhao Y L, et al. Radiomics-based machine learning to predict the recurrence of hepatocellular carcinoma: a systematic review and meta-analysis[J]. Acad Radiol,2024,31(2):467-479. [15] 楚伟可,吴雪,张鹏,等. 炎症标志物对早期小肝癌行射频消融术预后的预测价值[J]. 临床肝胆病杂志,2022,38(4):843-850. [16] Tu H B, Chen L H, Huang Y J, et al. Novel model combining contrast-enhanced ultrasound with serology predicts hepatocellular carcinoma recurrence after hepatectomy[J]. World J Clin Cases,2021,9(24):7009-7021. [17] 卢帅行,张丽霞,龚辰,等.术后预后营养指数与肝细胞癌切除术后严重并发症的关系[J].中国普外基础与临床杂志, 2022, 29(10):1344-1349. [18] 王瑛,袁鹤立,赵利,等. 伴营养不良风险的原发性肝癌患者临床特征及预后因素分析[J]. 中西医结合肝病杂志,2022,32(6):494-498. [19] Ni Z, Wu B, Li M, et al. Prediction model and nomogram of early recurrence of hepatocellular carcinoma after radiofrequency ablation based on logistic regression analysis[J]. Ultrasound Med Biol,2022,48(9):1733-1744. [20] 胡相友,易明超,卢攀.肝癌切除术和TACE治疗后肿瘤复发的预测模型构建与评估[J].现代医学, 2022, 50(1):41-46. |